Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism

Thyroid

Volumn 8, Issue 1, 1998, Pages 49-52

  Manso, Paulo G ^a   Furlanetto, Reinaldo P ^a   Wolosker, Angela M B ^a   Paiva, Elias R ^a   De Abreu, Mariza T ^a   Maciel, Rui M B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THYROID SCINTISCANNING; THYROTOXICOSIS; TREATMENT OUTCOME;

EID: 0031943906     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.49     Document Type: Article

References (37)

1. DeGroot LJ, German CA, Pinchera A, Bartalena L, Marcocci C, Wiersinga WM, Prummel M, Wartofsky L 1995 Therapeutic controversies: Radiation and Graves' ophthalmopathy. J Clin Endocrinol Metab 80:339-349.
2. Burch HB, Wartofsky L 1993 Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 14:747-793.
3. Bahn RS, Heufelder AE 1993 Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475.
4. Werner SC, Coelho B, Quimby EH 1957 Ten year results of I-131 therapy of hyperthyroidism. Bull NY Acad Med 33:783-806.
5. Hamilton HE, Schultz RO, De Gowin EL 1960 The endocrine eye lesion in hyperthyroidism. Arch Intern Med 105:675-685.
6. Kriss JP, Pleshakov V, Rosemblum AL, Holderness M, Sharp G, Utiger R 1967 Studies on the pathogenesis of ophthalmopathy of Graves' disease. J Clin Endocrinol Metab 27:582-593.
7. Pequegnat EP, Mayberry WE, McConahey WM, Wyse EP 1967 Large doses of radioiodine in Graves' disease: Effect on ophthalmopathy and long-acting thyroid stimulator. Mayo Clin Proc 42:802-811.
8. Hamilton RD, Mayberry WE, McConahey WM, Hanson KG 1967 Ophthalmopathy of Graves' disease: A comparison between patients treated surgically and patients treated with radioiodine. Mayo Clin Proc 42:812-818.
9. Hetzel BS, Mason EK, Kwan WH 1967 Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis. Austr Ann Med 17:307-311.
10. 131I therapy. Proc R Soc Med 62:15-18.
11. Barbosa J, Wong E, Doe RP 1972 Ophthalmopathy of Graves' disease: Outcome after treatment with radioactive iodine, surgery, or antithyroid drugs. Arch Intern Med 130:111-113.
12. Aron-Rosa D, Pérez R, Abitbol Y 1973 Malignant exophthalmos after iodine-131 treatment. Mod Probl Ophthalmol 14:432-434.
13. Gwinup G, Elias AN, Ascher MS 1982 Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 247:2135-2138.
14. Calissendorf BM, Soderstrom M, Alveryd A 1986 Ophthalmopathy and hyperthyroidism. A comparison between patients receiving different antithyroid treatments. Acta Ophthalmol (Copenh) 64:698-701.
15. Sridama V, DeGroot LJ 1989 Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 87:70-73.
16. Vestergaard H, Laurberg P 1989 Radioiodine and aggravation of Graves' ophthalmopathy. Lancet 2:47.
17. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1352.
18. Barth A, Probst P, Burgi H 1991 Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine. J Endocrinol Invest 14:209-212.
19. Vasquez-Chavez C, Nishimura ME, Espinosa SL, Delgado Falfari A, Sainz de Viteri M 1992 Effect of the treatment of hyperthyroidism on the course of exophthalmos. Rev Invest Clin 44:241-247.
20. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, Taube A 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
21. Fernandez Sanchez JR, Rosell Pradas J, Carazo Martinez O, Torres Vela E, Escobar Jimenez F, Garbin Fuentes I, Vara Thorbeck R 1993 Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 80:1134-1136.
22. Hilal ST, Trokel SL 1977 Computerized tomography of the orbit using thin sections. Semin Roentgenol 12:137-147.
23. Glantz AS 1987 Primer of Biostatistics, 2nd ed. McGraw-Hill Book Co, New York.
24. Teng CS, Yeo PPB 1977 Ophthalmic Graves' disease: natural history and detailed thyroid function studies. Br Med J 1:273-5.
25. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130:494-497.
26. Prummel MF, Wiersinga WM, Mourits MP, Koorneef L, Berghout A, van der Gaag R 1989 Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism. Acta Endocrinol (Copenh) 121(Suppl 2):185-189.
27. Prummel MF, Wiersinga WM, Mourits MP, Koorneef L, Berghout A, van der Gaag R 1990 Influence of abnormal thyroid function on the severity of accompanying Graves' ophthalmopathy. Arch Intern Med 150:1098-1101.
28. Kung AWC, Yau CC, Cheng A 1994 The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: Prognostic factors and the role of methimazole. J Clin Endocrinol Metab 79:542-546.
29. Utiger RD 1992 Pathogenesis of Graves' ophthalmopathy. N Engl J Med 326:1772-1773.
30. Solem JH, Segaard E, Ytteborg J 1979 The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study. Acta Med Scand 205:111-14.
31. Tengroth B 1961 Endocrine exophthalmos: Effects of thyrotropin preparations and thyrotropin isomers. Quantitative evaluations in guinea pigs. Acta Ophthalmol (Suppl. 65): 1-64.
32. Almqvist S, Algvere P 1972 Hypothyroidism in progressive ophthalmopathy of Graves' disease. Acta Ophthalmol 50:761-70.
33. Sjoberg HE, Saaf M, Bostrom L, Lundell G, Tallstedt L 1989 Observations on progress periods in Graves' ophthalmopathy. Acta Endocrinol (Copenh) 121(Suppl 2):179-81.
34. Karlsson FA, Dahberg PA, Jansson R, Westermark K, Enoksson P 1989 Importance of TSH receptor activation in the development of severe endocrine ophthalmopathy. Acta Endocrinol 121(Suppl. 2):132-41.
35. Salvi M, Zhang Z-G, Haegert D, Woo M, Liberman A, Cadarso L, Wall JR 1990 Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 70:89-94.
36. Just M, Kahaly G, Higer H 1991 Graves' ophthalmopathy: Role of MRI imaging in radiation therapy. Radiology 179:187-190.
37. Villadolid MC, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, Kiriyama T, Uetani M, Nagataki S 1995. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle enlargement by magnetic resonance. J Clin Endocrinol Metab 80:2830-2833.